Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline as supportive therapy in Parkinson's disease
2014-005562-30Phase 4Completed
- Sponsor
- PIAM Farmaceutici
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of citicoline in Parkinson's disease (PD), sponsored by PIAM Farmaceutici. Primary endpoint: Change in total MDS-UPDRS score at week 24 versus baseline. Started Nov 2020; status: completed.
02
Drugs
citicoline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2014-005562-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005562-30.